Evidence map›Paper›PMID 32229536›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2020

Cytomegalovirus Coinfection Is Associated with Increased Vascular-Homing CD57

Bonnie Chen, Stephen R Morris, Soumya Panigrahi, Gillian M Michaelson, Jonathan M Wyrick, Alexey A Komissarov, Daria Potashnikova, Anna Lebedeva, Souheil-Antoine Younes, Karem Harth and 10 more

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Mouse Models of HIV-Associated Atherosclerosis.International journal of molecular sciences · 2025
    Review
  6. Targeting PD-1 and CD85j can restore intratumoral CD4Journal for immunotherapy of cancer · 2025
    Article
  7. Article
  8. Review
  9. Observational
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. CD4Frontiers in immunology · 2023
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 2 countries.

Bonnie ChenCenter for AIDS Research, Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH 44106.
Stephen R MorrisLouis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106.ORCID 0000-0003-3232-8329
Soumya PanigrahiCenter for AIDS Research, Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH 44106.
Gillian M MichaelsonCenter for AIDS Research, Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH 44106.
Jonathan M WyrickCenter for AIDS Research, Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH 44106.
Alexey A KomissarovLaboratory of Atherothrombosis, Moscow State University of Medicine and Dentistry, Moscow 127473, Russia.
Daria PotashnikovaLaboratory of Atherothrombosis, Moscow State University of Medicine and Dentistry, Moscow 127473, Russia.ORCID 0000-0002-0098-827X
Anna LebedevaLaboratory of Atherothrombosis, Moscow State University of Medicine and Dentistry, Moscow 127473, Russia.
Souheil-Antoine YounesCenter for AIDS Research, Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH 44106.
Karem HarthHarrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center/Case Western Reserve University, Cleveland, OH 44106.
Vikram S KashyapHarrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center/Case Western Reserve University, Cleveland, OH 44106.
Elena VasilievaLaboratory of Atherothrombosis, Moscow State University of Medicine and Dentistry, Moscow 127473, Russia.
Leonid MargolisEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892.
David A ZidarLouis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106.
Scott F SiegCenter for AIDS Research, Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH 44106.ORCID 0000-0002-1769-8682
Carey L ShiveLouis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106.
Nicholas T FunderburgDivision of Medical Laboratory Science, School of Health and Rehabilitation Sciences, Ohio State University, Columbus, OH 43210; and.
Sara GianellaCenter for AIDS Research, Division of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, CA 92093.ORCID 0000-0002-9927-0849
Michael M LedermanCenter for AIDS Research, Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH 44106.
Michael L FreemanCenter for AIDS Research, Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH 44106; MLF62@case.edu.ORCID 0000-0002-7690-5258
University Hospitals of Cleveland · USMoscow State University of Medicine and Dentistry · RULouis Stokes Cleveland VA Medical Center · USNational Institutes of Health · USThe Ohio State University · USUniversity of California San Diego · US

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI Alan David Levine · 1994 to 2026
$50.0M
Case Clinical Trials Unit: Administrative Supplement NOSI AI-20-031.UM1AI069501 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI George Yendewa · 2012 to 2026
$40.4M
Primary Infection Resource Consortium (PIRC)R24AI106039 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LITTLE, SUSAN JANET · 2013 to 2021
$23.1M
Case AIDS Clinical Trials UnitU01AI069501 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI LEDERMAN, MICHAEL MARCEL · 2007 to 2011
$14.7M
Viral transmission and pathogenesis in human tissuesZIAHD008968 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI MARGOLIS, LEONID B. · 2018 to 2023
$12.2M
Specimen Acquisition and Distribution CoreP01AI076174 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI LANDAY, ALAN L · 2008 to 2012
$10.9M
Revealing Reservoirs during Rebound (R3)P01AI131385 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEGRUTTOLA, VICTOR GERARD · 2017 to 2021
$8.7M
Cellular mediators of vascular inflammation in treated HIV-infectionR01HL134544 · NHLBI · OHIO STATE UNIVERSITY · PI FUNDERBURG, NICHOLAS T. · 2016 to 2019
$3.2M
Effect of Declining Sex Hormones on HIV persistence in HIV Infected Women on ARTR21HD094646 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GIANELLA WEIBEL, SARA · 2017 to 2018
$441k
Role of IL-6 and IL-1b in immune dysfunction during aging, HIV, and HCV infectionIK2CX001471 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI SHIVE, CAREY LYNN · 2017 to 2021
–
CSRD VA IK2 CX001471NCATS NIH HHS UL1 TR001442NHLBI NIH HHS R01 HL134544NIAID NIH HHS P01 AI076174NIAID NIH HHS P01 AI131385NIAID NIH HHS P30 AI036214NIAID NIH HHS P30 AI036219NIAID NIH HHS R24 AI106039NIAID NIH HHS U01 AI069501NIAID NIH HHS UM1 AI069501NICHD NIH HHS R21 HD094646
6 · The paper itself

Abstract

Cytotoxic CD4 T cells are linked to cardiovascular morbidities and accumulate in both HIV and CMV infections, both of which are associated with increased risk of cardiovascular disease (CVD). In this study, we identify CMV coinfection as a major driver of the cytotoxic phenotype, characterized by elevated CD57 expression and reduced CD28 expression, in circulating CD4 T cells from people living with HIV infection, and investigate potential mechanisms linking this cell population to CVD. We find that human CD57

Indexed as

Blood VesselsCD28 AntigensCD4-Positive T-LymphocytesCD57 AntigensCD58 AntigensCell MovementChemokine CX3CL1CoinfectionCX3C Chemokine Receptor 1CytomegalovirusCytomegalovirus InfectionsCytotoxicity, ImmunologicHIV-1HIV InfectionsHumansPlaque, AtheroscleroticCD28 AntigensCD57 AntigensCD58 AntigensChemokine CX3CL1CX3C Chemokine Receptor 1CX3CR1 protein, humanCXCR3 protein, humanReceptors, CXCR3

Identifiers

PMID32229536
PMCPMC7315224
OpenAlexW3013245257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.